StatSure Diagnostic Systems Performance
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and StatSure Diagnostic are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days StatSure Diagnostic Systems has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, StatSure Diagnostic is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors. ...more
StatSure |
StatSure Diagnostic Relative Risk vs. Return Landscape
If you would invest (100.00) in StatSure Diagnostic Systems on October 13, 2025 and sell it today you would earn a total of 100.00 from holding StatSure Diagnostic Systems or generate -100.0% return on investment over 90 days. StatSure Diagnostic Systems is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than StatSure, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
StatSure Diagnostic Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for StatSure Diagnostic's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as StatSure Diagnostic Systems, and traders can use it to determine the average amount a StatSure Diagnostic's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| SSUR |
Based on monthly moving average StatSure Diagnostic is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of StatSure Diagnostic by adding StatSure Diagnostic to a well-diversified portfolio.
StatSure Diagnostic Fundamentals Growth
StatSure Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of StatSure Diagnostic, and StatSure Diagnostic fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on StatSure Pink Sheet performance.
| Return On Asset | -1.14 | |||
| Profit Margin | 0.39 % | |||
| Operating Margin | (0.70) % | |||
| Current Valuation | 1.45 M | |||
| Price To Sales | 0.11 X | |||
| Revenue | 974.32 K | |||
| EBITDA | (664.07 K) | |||
| Book Value Per Share | (0.66) X | |||
| Cash Flow From Operations | (332.34 K) | |||
| Earnings Per Share | (0.15) X | |||
| Total Asset | 410.81 K | |||
| Retained Earnings | (50.43 M) | |||
| Current Asset | 168 K | |||
| Current Liabilities | 2.76 M | |||
Things to note about StatSure Diagnostic performance evaluation
Checking the ongoing alerts about StatSure Diagnostic for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for StatSure Diagnostic help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| StatSure Diagnostic is not yet fully synchronised with the market data | |
| StatSure Diagnostic has some characteristics of a very speculative penny stock | |
| StatSure Diagnostic has a very high chance of going through financial distress in the upcoming years | |
| The company has a current ratio of 0.06, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist StatSure Diagnostic until it has trouble settling it off, either with new capital or with free cash flow. So, StatSure Diagnostic's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like StatSure Diagnostic sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for StatSure to invest in growth at high rates of return. When we think about StatSure Diagnostic's use of debt, we should always consider it together with cash and equity. | |
| StatSure Diagnostic generates negative cash flow from operations |
- Analyzing StatSure Diagnostic's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether StatSure Diagnostic's stock is overvalued or undervalued compared to its peers.
- Examining StatSure Diagnostic's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating StatSure Diagnostic's management team can have a significant impact on its success or failure. Reviewing the track record and experience of StatSure Diagnostic's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of StatSure Diagnostic's pink sheet. These opinions can provide insight into StatSure Diagnostic's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in StatSure Pink Sheet
If you are still planning to invest in StatSure Diagnostic check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the StatSure Diagnostic's history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |